학술논문
A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma.
Document Type
journal article
Author
Source
Journal of Thoracic Oncology; 2012 Sep, Vol. 7 Issue 9, p1449-1456, 8p
Subject
Language
ISSN
15560864